Phathom Pharmaceuticals Inc (PHAT)
Healthcare
Biotechnology
9.00 $
+2.6%
vs. previous close
Closing price · As of: 3. Aug 2026
Phathom Pharmaceuticals Inc (PHAT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -1.9 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -32 | -44 | -69 | -71 | -64 | -63 | -85 | -63 | -14 | -5.0 | -16 | -1.9 | -37 | |
| 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.5 | |
| 6.1 | 25 | 5.6 | 6.1 | 5.6 | 6.7 | 5.5 | 8.3 | 9.3 | 5.6 | 5.5 | 6.7 | 27 | |
| -2.4 | 0.7 | -7.0 | -0.6 | 1.4 | -9.0 | -8.9 | -6.0 | -1.6 | 4.0 | 1.5 | 2.6 | 6.7 | |
| 0.9 | 0.5 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.1 | 0.0 | 0.2 | |
| -0.9 | -0.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | -0.1 | -0.1 | 0.0 | -0.2 | |
| – | – | – | – | 0.0 | 25 | 0.0 | 0.0 | 0.0 | 0.0 | -56 | 0.0 | -56 | |
| 0.0 | 212 | 9.9 | 25 | 122 | 26 | 0.0 | 0.1 | -0.3 | -0.1 | 67 | 3.6 | 70 | |
| -33 | 168 | -59 | -46 | 58 | -37 | -85 | -63 | -14 | -5.2 | 51 | 1.6 | 33 | |
| -33 | -44 | -69 | -71 | -63 | -63 | -85 | -63 | -14 | -4.9 | -16 | -2.0 | -37 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.